The Clinical Operations Team at Sonoma Biotherapeutics is responsible for the planning, execution, and oversight of clinical trials for engineered regulatory T cell therapies. This team ensures compliance with regulatory requirements, coordinates multidisciplinary efforts, and manages project timelines and budgets to facilitate successful study outcomes. By collaborating closely with clinical development, regulatory affairs, and program management, they play a crucial role in advancing innovative treatments for autoimmune and inflammatory diseases.
View all